Evaluation of Efficacy and Safety of Intella Dermal Filler in Moderate to Severe Nasolabial Folds

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

February 14, 2024

Study Completion Date

February 28, 2025

Conditions

Nasolabial Fold Correction

Interventions

DEVICE

Hyaluronic acid combined with calcium hydroxyapatite injection

The filler was injected in nasolabial folds in a before-after setting

Trial Locations (1)

Orchid Pharmed, Medical Department, Tehran

All Listed Sponsors

lead

Espad Pharmed

INDUSTRY

NCT07102537 - Evaluation of Efficacy and Safety of Intella Dermal Filler in Moderate to Severe Nasolabial Folds | Biotech Hunter | Biotech Hunter